Improvement of variant reclassification in genetic neurodevelopmental conditions
Genetics in Medicine Open · 2024 · 2 · 101845
DOI: 10.1016/j.gimo.2024.101845 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine Open, 2024. Verfasst von Michelle Kowanda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Geisinger Autism & Developmental Medicine Institute, Lewisburg, PA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, National Institutes of Health, Simons Foundation.
Abstract (Originalsprache)
Purpose
Limited knowledge about disease mechanisms, few published cases, and the lack of functional assessment of variants for neurodevelopmental genetic disorders challenge diagnostic classification for variants and increase the frequency of variants of uncertain significance (VUS). Because inheritance patterns aid in variant interpretation for neurodevelopmental conditions, genetic testing including only the proband leads to larger numbers of VUS than testing strategies that include the parents.
Methods
We reinterpreted genetic variants submitted to the Simons Searchlight research registry using American College of Medical Genetics and Genomics variant interpretation guidelines, familial cascade testing, and literature curation with annual VUS reevaluation.
Results
Simons Searchlight has independently evaluated 2834 genetic laboratory reports; 20.4% of variants (1.7% copy-number variants and 18.7% monogenic variants) were reclassified with 230 upgrades and 173 downgrades in pathogenicity. Of 351 monogenic VUS on the original clinical test report, 25.4% were reclassified as likely pathogenic or pathogenic. VUS in SCN2A, SLC6A1, or STXBP1 were more likely to have VUS reclassified compared with variants in other genes.
Conclusion
Regular reevaluation of neurodevelopmental genetic variants can be helpful because relevant variant reclassifications occur frequently and may affect clinical care. Simons Searchlight contributes to the international neurodevelopmental community by systematically reviewing uncertain variants annually and providing reclassified variants to participants, researchers, and ClinVar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geisinger Autism & Developmental Medicine Institute, Lewisburg, PA.
- Laboratory of Systems Neuroscience, Institute for Neuroscience, Department of Health Science and Technology, Swiss Federal Institute of Technology ETH, Zurich, Switzerland.
- Rare Disease Translational Center, The Jackson Laboratory, Bar Harbor, ME.
- Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.
- Department of Pediatrics, Boston Children's Hospital, Boston, MA.
- Faculty of Pediatrics, Harvard Medical School, Boston, MA.
Förderung
- NHGRI NIH HHS
- National Institutes of Health
- Simons Foundation
Zitieren
APA
Kowanda, M., Smith, R. S., Lundy, J., Kentros, C., Kleinman, E., Walsh, L. K., Schratt, G., Taylor, C. M., & Chung, W. K. (2024). Improvement of variant reclassification in genetic neurodevelopmental conditions. Genetics in Medicine Open, 2, 101845. https://doi.org/10.1016/j.gimo.2024.101845
Vancouver
Kowanda M, Smith RS, Lundy J, Kentros C, Kleinman E, Walsh LK, et al. Improvement of variant reclassification in genetic neurodevelopmental conditions. Genetics in Medicine Open. 2024;2:101845. doi:10.1016/j.gimo.2024.101845
BibTeX
@article{Kowanda2024,
author = {Kowanda, Michelle and Smith, Rebecca Sheedy and Lundy, Jamie and Kentros, Catherine and Kleinman, Elisheva and Walsh, Lauren Kasparson and Schratt, Gerhard and Taylor, Cora M and Chung, Wendy K},
title = {Improvement of variant reclassification in genetic neurodevelopmental conditions},
journal = {Genetics in Medicine Open},
year = {2024},
volume = {2},
pages = {101845},
doi = {10.1016/j.gimo.2024.101845}
}
EUVIMED